NCT06724783

Brief Summary

The goal of this randomized controlled clinical trial is to compare the use of two covering collagen membranes in a bone augmentation procedure around single implants and to assess three different veneering approaches on crowns in patients lacking a single tooth in the esthetic zone. The main aims include:

  1. 1.Bone stability, i.e. the difference in the bone defect depth 4 months after bone augmentation
  2. 2.The occurrence of ceramic restoration chipping at the inserted single crowns after 5 years.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for phase_4

Timeline
53mo left

Started Jun 2023

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress39%
Jun 2023Sep 2030

Study Start

First participant enrolled

June 30, 2023

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

May 15, 2024

Completed
7 months until next milestone

First Posted

Study publicly available on registry

December 9, 2024

Completed
5.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2030

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2030

Last Updated

December 9, 2024

Status Verified

December 1, 2024

Enrollment Period

7 years

First QC Date

May 15, 2024

Last Update Submit

December 4, 2024

Conditions

Keywords

guided bone regeneration (GBR)collagen membranedental implantszirconiamonolithic ceramic fixed dental prosthesis (singe crowns)

Outcome Measures

Primary Outcomes (2)

  • Surgical part: bone stability

    The difference in the bone defect depth after bone augmentation (baseline) and after 4 months between the groups.

    4 months

  • Restorative part: chipping rates

    The occurrence of ceramic chipping at the inserted single crowns

    5 years

Secondary Outcomes (3)

  • Bone level changes

    1,3,5 years

  • Soft tissue volume changes

    1,3,5 years

  • Restoration technical parameters

    1,3,5 years

Study Arms (2)

Standard resorbable collagen membrane

ACTIVE COMPARATOR

GBR with implant placement

Device: Collagen membrane

Compressed, stronger resorbable collagen membrane

EXPERIMENTAL

GBR with implant placement

Device: Collagen membrane

Interventions

Implant placement with simultaneous GBR covered with a collagen membrane

Compressed, stronger resorbable collagen membraneStandard resorbable collagen membrane

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed Consent signed by the subject
  • ≥18 years of age
  • No active periodontal disease
  • Full-mouth plaque score and full-mouth bleeding score \<25%.
  • Patients in need of an implant-supported crown at a single-tooth gap in the aesthetic region: 11-15, 21-25, 31-35, 41-45 (FDI)
  • Patients in need of GBR during implant placement (1-stage procedure)
  • Presence of mesial and distal natural teeth or implant
  • Implant placement at least 6 weeks after tooth extraction
  • No need for soft tissue grafting

You may not qualify if:

  • Any conditions or circumstances which would interfere with the requirements for oral surgery
  • Patients with large bone defects, in need of a primary bone augmentation (two-stage procedure)
  • Allergy to any implant metallic component
  • Allergy to collagen
  • Previous oral-maxillo-facial radiotherapy
  • Any disorders in the planned implant area such as previous tumors, chronic bone
  • disease (such as rheumatoid disease)
  • Any ongoing application of interfering medication (steroid therapy, bisphosphonate, etc.)
  • Alcohol or drug abuse
  • No need for soft tissue grafting
  • Patients with inadequate oral hygiene or persistent oral infection
  • Clinically significant concomitant diseases (e.g. renal failure, hepatic disfunction, cardiovascular diseases)
  • Heavy smokers (\>10 cigarettes/day)
  • Uncontrolled diabetes
  • Severe bruxism or other destructive habits
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Geneva

Geneva, Canton of Geneva, Switzerland

RECRUITING

Study Officials

  • Malin Strasding, Dr dent med

    University Clinic of Dental Medicine, University of Geneva

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Malin Strasding, Dr dent med

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A two parallel arm (test and control) non-inferiority, prospective, randomized controlled, monocentric, open-label clinical trial (surgical part) A three parallel arm (test, two controls) prospective, randomized controlled, monocentric, open-label clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Senior lecturer

Study Record Dates

First Submitted

May 15, 2024

First Posted

December 9, 2024

Study Start

June 30, 2023

Primary Completion (Estimated)

June 30, 2030

Study Completion (Estimated)

September 30, 2030

Last Updated

December 9, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations